184 related articles for article (PubMed ID: 2120125)
1. Restricted accumulation of globotriaosylceramide in the hearts of atypical cases of Fabry's disease.
Ogawa K; Sugamata K; Funamoto N; Abe T; Sato T; Nagashima K; Ohkawa S
Hum Pathol; 1990 Oct; 21(10):1067-73. PubMed ID: 2120125
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of glycosphingolipids in spinal and sympathetic ganglia of a symptomatic heterozygote of Fabry's disease.
Hozumi I; Nishizawa M; Ariga T; Inoue Y; Ohnishi Y; Yokoyama A; Shibata A; Miyatake T
J Neurol Sci; 1989 May; 90(3):273-80. PubMed ID: 2500499
[TBL] [Abstract][Full Text] [Related]
3. Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy.
Elleder M; Bradová V; Smíd F; Budĕsínský M; Harzer K; Kustermann-Kuhn B; Ledvinová J; Bĕlohlávek ; Král V; Dorazilová V
Virchows Arch A Pathol Anat Histopathol; 1990; 417(5):449-55. PubMed ID: 2173254
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and clinical analysis of accumulated glycolipids in symptomatic heterozygotes of angiokeratoma corporis diffusum (Fabry's disease) in comparison with hemizygotes.
Hozumi I; Nishizawa M; Ariga T; Miyatake T
J Lipid Res; 1990 Feb; 31(2):335-40. PubMed ID: 2157788
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of glycosphingolipid in urinary renal tubular cells in Fabry's disease.
Chatterjee S; Gupta P; Pyeritz RE; Kwiterovich PO
Am J Clin Pathol; 1984 Jul; 82(1):24-8. PubMed ID: 6430064
[TBL] [Abstract][Full Text] [Related]
6. [Visceral manifestations of glycosphingolipidosis (Fabry's disease)].
Zaĭrat'iants OV; Bruk EI; Berestova AV; Mendel'son MM
Arkh Patol; 1987; 49(6):58-63. PubMed ID: 3117021
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease.
Eng CM; Guffon N; Wilcox WR; Germain DP; Lee P; Waldek S; Caplan L; Linthorst GE; Desnick RJ;
N Engl J Med; 2001 Jul; 345(1):9-16. PubMed ID: 11439963
[TBL] [Abstract][Full Text] [Related]
8. Fabry's disease with partially deficient hydrolysis of ceramide trihexoside.
Kobayashi T; Kira J; Shinnoh N; Goto I; Kuroiwa Y
J Neurol Sci; 1985 Feb; 67(2):179-85. PubMed ID: 2984338
[TBL] [Abstract][Full Text] [Related]
9. Subclinical Fabry's disease occurring in the context of IgA nephropathy.
Kawamura O; Sakuraba H; Itoh K; Suzuki Y; Doi M; Kuwabara H; Oshima S; Abe S; Warabi H; Yoshizawa N
Clin Nephrol; 1997 Feb; 47(2):71-5. PubMed ID: 9049452
[TBL] [Abstract][Full Text] [Related]
10. Fabry's disease--a case report and review of literatures reported in Korea.
Lee SY; Kim SJ; Lee JI; Kim ES; Lee CH; Kim JH; Jeong HJ; Ha SK
Yonsei Med J; 1998 Feb; 39(1):67-72. PubMed ID: 9529988
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of ceramide trihexoside in cultured skin fibroblasts from Fabry's patients, carriers and normal controls.
Kobayashi T; Shinnoh N; Kuroiwa Y
J Neurol Sci; 1984 Aug; 65(2):169-77. PubMed ID: 6090593
[TBL] [Abstract][Full Text] [Related]
12. An atypical variant of Fabry's disease in men with left ventricular hypertrophy.
Nakao S; Takenaka T; Maeda M; Kodama C; Tanaka A; Tahara M; Yoshida A; Kuriyama M; Hayashibe H; Sakuraba H
N Engl J Med; 1995 Aug; 333(5):288-93. PubMed ID: 7596372
[TBL] [Abstract][Full Text] [Related]
13. A female heterozygous patient with Fabry's disease with renal accumulation of trihexosylceramide detected with a monoclonal antibody.
Fukushima M; Tsuchiyama Y; Nakato T; Yokoi T; Ikeda H; Yoshida S; Kusumoto T; Itoh K; Sakuraba H
Am J Kidney Dis; 1995 Dec; 26(6):952-5. PubMed ID: 7503071
[TBL] [Abstract][Full Text] [Related]
14. Early renal failure in Fabry's disease.
Sheth KJ; Roth DA; Adams MB
Am J Kidney Dis; 1983 May; 2(6):651-4. PubMed ID: 6405613
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural and biochemical liver analyses in Fabry's disease.
Meuwissen SG; Dingemans KP; Strijland A; Tager JM; Ooms BC
Hepatology; 1982; 2(2):263-8. PubMed ID: 6802742
[TBL] [Abstract][Full Text] [Related]
16. Fabry's disease without angiokeratomas showing unusual eccrine gland vacuolation.
Idoate MA; Pardo-Mindan FJ; Gonzalez Alamillo C
J Pathol; 1992 May; 167(1):65-8. PubMed ID: 1625060
[TBL] [Abstract][Full Text] [Related]
17. Primary Human Colon Epithelial Cells (pHCoEpiCs) Do Express the Shiga Toxin (Stx) Receptor Glycosphingolipids Gb3Cer and Gb4Cer and Are Largely Refractory but Not Resistant towards Stx.
Detzner J; Püttmann C; Pohlentz G; Humpf HU; Mellmann A; Karch H; Müthing J
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576167
[TBL] [Abstract][Full Text] [Related]
18. Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation.
Kaye EM; Kolodny EH; Logigian EL; Ullman MD
Ann Neurol; 1988 May; 23(5):505-9. PubMed ID: 3133979
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of VEGFα as a biomarker of endothelial dysfunction in aortic tissue of α-GAL-Tg/KO mice and its upregulation in the serum of patients with Fabry's disease.
Lund N; Wieboldt H; Fischer L; Muschol N; Braun F; Huber T; Sorriento D; Iaccarino G; Müllerleile K; Tahir E; Adam G; Kirchhof P; Fabritz L; Patten M
Front Cardiovasc Med; 2024; 11():1355033. PubMed ID: 38374995
[TBL] [Abstract][Full Text] [Related]
20. [A case of Fabry's disease with chronic renal failure].
Suzuki T; Fujino T; Sugasawa M; Kohara Y; Toyama K; Sato T; Yasuda T; Sugiyama M; Maeba T; Owada S; Ishida M
Nihon Jinzo Gakkai Shi; 1999 Jun; 41(4):448-53. PubMed ID: 10441995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
